ChristopherThomasSuMD

Internal Medicine • Seattle, WA

Physician

Join to view full profile

Dr. Su is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Su's full profile

Already have an account?

Office
325 9th Ave
Seattle, WA 98104
Phone+1 206-520-5000

Education & Training

Icahn School of Medicine at Mount SinaiClass of 2015

Certifications & Licensure

WA State Medical License 2022 - 2026
MI State Medical License 2019 - 2023
NY State Medical License 2018 - 2020
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

4 citations
Financial Toxicity, Time Toxicity, and Quality of Life in Multiple Myeloma.
Rahul Banerjee, Andrew J Cowan, Marivel Ortega, Constance Missimer, Paul A Carpenter
Clinical Lymphoma, Myeloma & Leukemia. 2024-07-01
Digital symptom assessment tools: the next frontier in financial toxicity screening.
Christopher T Su, Veena Shankaran
Nature Reviews. Clinical Oncology. 2024-02-01
5 citations
Heterogeneous Expression of PD-L1, B7x, B7-H3, and HHLA2 in Pulmonary Sarcomatoid Carcinoma and the Related Regulatory Signaling Pathways.
Feng Wang, Ayse Ece Cali Daylan, Lei Deng, Jihua Yang, Janaki Sharma
Cancers. 2023-06-27

Journal Articles

Evaluation of the Safety and Efficacy of Immunotherapy Rechallenge in Patients with Renal Cell Carcinoma
Praful Ravi, Charlene Mantia, Christopher Su, Neeraj Agarwal, Yousef Zakharia, Rana R Mckay, Vivek Narayan, Ajjai Alva, Bradley A Mcgregor, David F Mcdermott, Toni K C..., JAMA Oncology

Authored Content

Evaluation of the Safety and Efficacy of Immunotherapy Rechallenge in Patients with Renal Cell CarcinomaMay 2020
Evaluation of the Safety and Efficacy of Immunotherapy Rechallenge in Patients with Renal Cell CarcinomaMay 2020

Press Mentions

ACA Eases Patient Financial Responsibility for Cancer SurvivorsJuly 19th, 2021
Financial Barriers Fell for Some Cancer Survivors After Affordable Care ActJuly 13th, 2021